Arkolith/Insider Trading/SPRB/Form 4

Spiegelman Daniel K

DirectorSPRUCE BIOSCIENCES, INC. (SPRB) · full profile →Form 4 · filed Dec 15, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
0 non-derivative · 6 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 11, 2025Disposed to issuer(D)88——0
Dec 11, 2025Grant(A)400——400
Dec 11, 2025Grant(A)88——88
Dec 11, 2025Grant(A)458——458
Dec 11, 2025Disposed to issuer(D)458——0
Dec 11, 2025Disposed to issuer(D)400——0

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001238403-25-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML